Sally-Ann Turner is the Founder and Managing Director of Bodyline Medical Clinics, a leading UK healthcare group specialising in obesity, diabetes, and women’s hormone health. With over 18 years at the helm, she has built Bodyline into a trusted, patient-centric provider with a strong national presence and a reputation for clinical excellence.

Under her leadership, Bodyline operates seven CQC-rated "Good" medi-spa clinics and clinical trial sites, treating approximately 2,000 patients each month. The company delivers bespoke clinical services and research solutions for corporates, health insurers, pharma, CROs, and site networks, supported by a large patient database and a GCP-trained medical team of over 30 clinicians.

Sally-Ann brings deep expertise in UK and international clinical pathways, regulatory compliance, and strategic growth. She works closely with regulators including the CQC, MHRA, and the Home Office, and leads Bodyline’s expansion into remote care and research-ready infrastructure.

Passionate about women’s health and innovation in obesity and diabetes care, Sally-Ann is committed to delivering impactful health solutions that drive better outcomes for patients and partners across the healthcare sector.